179 related articles for article (PubMed ID: 19132974)
21. Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate.
Hao J; Pang YT; Wang DY
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):267-75. PubMed ID: 16455376
[TBL] [Abstract][Full Text] [Related]
22. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.
Bachert C; Gevaert P; Holtappels G; Johansson SG; van Cauwenberge P
J Allergy Clin Immunol; 2001 Apr; 107(4):607-14. PubMed ID: 11295647
[TBL] [Abstract][Full Text] [Related]
23. Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment.
Embid C; Fernández-Bertolín L; Pujols L; Alobid I; Mullol J; Picado C
Arch Bronconeumol; 2011 Mar; 47(3):115-21. PubMed ID: 21288619
[TBL] [Abstract][Full Text] [Related]
24. Nasal inflammation induced by a common cold: comparison between controls and patients with nasal polyposis under topical steroid therapy.
Dassonville C; Bonfils P; Momas I; Seta N
Acta Otorhinolaryngol Ital; 2007 Apr; 27(2):78-82. PubMed ID: 17608135
[TBL] [Abstract][Full Text] [Related]
25. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues.
Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J
J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients.
Gevaert P; Hellman C; Lundblad L; Lundahl J; Holtappels G; van Cauwenberge P; Tavernier J; Bachert C
Allergy; 2009 May; 64(5):725-32. PubMed ID: 19170670
[TBL] [Abstract][Full Text] [Related]
27. Cytokine levels in nasal secretions in asthmatic and nonasthmatic patients with nasal polyposis.
Perić A; Vojvodić D; Radulović V; Miljanović O
Kulak Burun Bogaz Ihtis Derg; 2010; 20(3):111-7. PubMed ID: 20465535
[TBL] [Abstract][Full Text] [Related]
28. Exhaled inflammatory markers in aspirin-induced asthma syndrome.
Carpagnano GE; Resta O; Gelardi M; Spanevello A; Di Gioia G; Giliberti T; Depalo A; Foschino Barbaro MP
Am J Rhinol; 2007; 21(5):542-7. PubMed ID: 17999786
[TBL] [Abstract][Full Text] [Related]
29. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis.
Tsicopoulos A; Shimbara A; de Nadai P; Aldewachi O; Lamblin C; Lassalle P; Walls AF; Sénéchal S; Levitt RC; Darras J; Hamid Q; Wallaert B
J Allergy Clin Immunol; 2004 Mar; 113(3):462-9. PubMed ID: 15007348
[TBL] [Abstract][Full Text] [Related]
30. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.
Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP
J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma.
Pujols L; Mullol J; Alobid I; Roca-Ferrer J; Xaubet A; Picado C
J Allergy Clin Immunol; 2004 Oct; 114(4):814-9. PubMed ID: 15480320
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of EMP1 is associated with epithelial hyperplasia and metaplasia in nasal polyps.
Yu XM; Li CW; Li YY; Liu J; Lin ZB; Li TY; Zhao L; Pan XL; Shi L; Wang de Y
Histopathology; 2013 Nov; 63(5):686-95. PubMed ID: 24033346
[TBL] [Abstract][Full Text] [Related]
33. [Effect of intranasal glucosteroid on the gene expression of interleukin-5 in nasal polyps].
Zhang L; Han DM; Zhou B; Fan EZ; Liu ZY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Nov; 39(11):672-5. PubMed ID: 15835818
[TBL] [Abstract][Full Text] [Related]
34. Nasal polyp inflammation. Effect of topical nasal steroid.
Kanai N; Denburg J; Jordana M; Dolovich J
Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress in nonallergic nasal polyps associated with bronchial hyperresponsiveness.
Cheng YK; Tsai MH; Lin CD; Hwang GY; Hang LW; Tseng GC; Shen PS; Chang WC
Allergy; 2006 Nov; 61(11):1290-8. PubMed ID: 17002704
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients.
Owens JM; Shroyer KR; Kingdom TT
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):579-87. PubMed ID: 16785401
[TBL] [Abstract][Full Text] [Related]
37. Effect of glucocorticoid on the MUC4 gene in nasal polyps.
Bai CH; Song SY; Kim YD
Laryngoscope; 2007 Dec; 117(12):2169-73. PubMed ID: 17891050
[TBL] [Abstract][Full Text] [Related]
38. [New insights into the pathology of nasal polyposis: the role of superantigens and IgE].
Van Cauwenberge P; Gevaert P; Van Hoecke H; Van Zele T; Bachert C
Verh K Acad Geneeskd Belg; 2005; 67(1):5-28; discussion 29-32. PubMed ID: 15828304
[TBL] [Abstract][Full Text] [Related]
39. The effect of high-dose topical corticosteroid therapy on prevention of recurrent nasal polyps after revision endoscopic sinus surgery.
Kang IG; Yoon BK; Jung JH; Cha HE; Kim ST
Am J Rhinol; 2008; 22(5):497-501. PubMed ID: 18684343
[TBL] [Abstract][Full Text] [Related]
40. The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps.
Beata RN; Wojciech F; Stanisław S; Ryszard M
Auris Nasus Larynx; 2005 Sep; 32(3):225-9. PubMed ID: 16024204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
